EnnoDC

📍 Paris, France👥 5 employees💰 Last funded Dec 2023
Biotechnology Research🌐 ennodc.com
Website LinkedIn
EnnoDC is a clinical-stage biotech company pioneering the development of first-in-class dendritic cell-targeting IgG4 CD40 and antigen-specific immunotherapies for cancer and infectious diseases. Our mission is to develop the next generation of immunotherapies using the latest scientific insights to develop antibodies for patients affected by cancer and infectious diseases.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in EnnoDC?
EnnoDC has 1 investors on record on gritt.io.
When did EnnoDC last raise funding?
The most recent investment in EnnoDC recorded on gritt.io was in December 2023.
What industry is EnnoDC in?
EnnoDC operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EnnoDC based?
EnnoDC is headquartered in Paris, France.